Related Experiment Video
Updated: Feb 25, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Down-regulated long non-coding RNA SNHG1 inhibits tumor genesis of colorectal carcinoma
Xiantao Sun1, Zhimin Wang2, Weitang Yuan1
1Department of Colorectal Surgery, The First Affiliated Hospital and Institute of Clinical Medicine, Zhengzhou University, Zhengzhou 450052, Henan, China.
Background:
Colorectal carcinoma (CRC) is the vital cancer mortality worldwide and the long noncoding RNAs (lncRNAs) is considered as an important biomarker. The aim of this study was to examine the influence of lncRNA-SNHG1in CRC, and explore the relationship of lncRNA-SNHG1 and CRC, and consequently find a new therapeutic target for CRC patients.
Methods:
This study used 80 CRC patients and several cancer cell lines, with RNA interference technology to find the function of SNHG1.
Results:
SNHG1 expression was higher in CRC tissue lines other than the cancer adjacent tissues. Moreover, down-regulated SNHG1 resulting in smaller tumor size and lighter tumor weight. Additionally, down-regulated SNHG1 inhibited cell migration, proliferation and colony formation, but promoted cell apoptosis.
Conclusion:
Our findings revealed that down-regulated SNHG1 could inhibit CRC tumor genesis and SNHG1 might act as an important potential therapeutic target in CRC treatment.
Insights
Down-regulating SNHG1, a long noncoding RNA, inhibits colorectal cancer (CRC) growth and spread. This finding suggests SNHG1 is a potential therapeutic target for treating CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal carcinoma (CRC) is a leading cause of cancer mortality globally.
- Long noncoding RNAs (lncRNAs) are emerging as critical biomarkers in cancer.
- Understanding lncRNA roles is vital for developing new CRC therapies.
Purpose of the Study:
- To investigate the role of lncRNA-SNHG1 in colorectal carcinoma.
- To explore the relationship between SNHG1 and CRC development.
- To identify SNHG1 as a potential therapeutic target for CRC.
Main Methods:
- Analysis of SNHG1 expression in 80 CRC patients and cancer cell lines.
- Utilized RNA interference technology to study SNHG1 function.
- Assessed tumor size, weight, cell migration, proliferation, colony formation, and apoptosis.
Main Results:
- SNHG1 expression was significantly elevated in CRC tissues compared to adjacent tissues.
- Down-regulation of SNHG1 led to reduced tumor size and weight.
- Inhibited cell migration, proliferation, and colony formation, while promoting apoptosis.
Conclusions:
- Down-regulated SNHG1 effectively inhibits colorectal cancer tumor genesis.
- SNHG1 represents a promising potential therapeutic target for CRC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
MicroRNAs
MicroRNAs
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...